Product Information

OLANZAPINE-FLUOXETINE 12-50 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $6.8195 per EA under NDC 00093550756. Its NADAC has been published 469 times since Nov 28, 2013.

FDA first approved this application on Jun 19, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLANZAPINE-FLUOXETINE 12-50 MG

Olanzapine and Fluoxetine
$6.8195per EA

Strength

50; 12 mg/1; mg/1

NDC

00093550756

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077528

FDA Approved

6/19/2012

TE Code

AB

On Market Since

6/19/2012

Pharmacological Classes

Price Statistics

The NADAC for OLANZAPINE-FLUOXETINE 12-50 MG has been published 469 times since Nov 28, 2013, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.

Current price$6.8195 per EA
All-time high$16.9398 (Dec 11, 2013)
All-time low$5.6431 (Apr 17, 2024)
52-week high$7.8373
52-week low$6.8195
Median price$10.0320
Average price$11.3389
Largest weekly change-33.5% (Apr 17, 2024)
Weeks tracked469
Tracking sinceNov 28, 2013

Price History

1W

-3.0%

1M

-3.0%

3M

-7.8%

6M

-8.3%

1Y

-12.5%

3Y

-19.6%

5Y

-32.0%

All

-59.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Olanzapine and Fluoxetine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OLANZAPINE-FLUOXETINE 12-50 MG?

The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 12-50 MG, manufactured by Teva Pharmaceuticals USA Inc., is $6.8195 per EA (NDC 00093550756), effective Aug 19, 2026.

How has the price of OLANZAPINE-FLUOXETINE 12-50 MG changed over time?

Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 12-50 MG has declined 59.7%. It has been tracked across 469 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 12-50 MG?

Since Nov 28, 2013, the NADAC for OLANZAPINE-FLUOXETINE 12-50 MG has ranged from a low of $5.6431 (Apr 17, 2024) to a high of $16.9398 (Dec 11, 2013), with a median of $10.0320 per EA.

Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 12-50 MG?

No other NADAC-published product currently shares the active ingredient and strength of OLANZAPINE-FLUOXETINE 12-50 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OLANZAPINE-FLUOXETINE 12-50 MG?

OLANZAPINE-FLUOXETINE 12-50 MG (NDC 00093550756) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.